Tumor suppressor maspin as a modulator of host immune response to cancer
Despite the promising clinical outcome, the primary challenge of the curative cancer immunotherapy is to overcome the dichotomy of the immune response: tumor-evoked immunostimulatory versus tumor-induced immunosuppressive. The goal needs to be two-fold, to re-establish sustainable antitumor-cancer...
Main Authors: | Sijana H. Dzinic, Maria M. Bernardo, Daniel S.M. Oliveira, Marian Wahba, Wael Sakr, Shijie Sheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2015-10-01
|
Series: | Bosnian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | https://bjbms.org/ojs/index.php/bjbms/article/view/783 |
Similar Items
-
The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment
by: Natasja L. de Vries, et al.
Published: (2016-06-01) -
Immune pressures drive the promoter hypermethylation of neoantigen genes
by: Ming Yi, et al.
Published: (2019-11-01) -
Recent Advances of Gold Compounds in Anticancer Immunity
by: Shuang Yue, et al.
Published: (2020-06-01) -
Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion
by: Li-Lian Gan, et al.
Published: (2020-07-01) -
New concepts in immunity to Neisseria gonorrhoeae: innate responses and suppression of adaptive immunity favor the pathogen, not the host
by: Yingru eLiu, et al.
Published: (2011-03-01)